These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 8573124)
1. In vivo antitumor effect of cytotoxic T lymphocytes engineered to produce interferon-gamma by adenovirus-mediated genetic transduction. Abe J; Wakimoto H; Tsunoda R; Okabe S; Yoshida Y; Aoyagi M; Hirakawa K; Hamada H Biochem Biophys Res Commun; 1996 Jan; 218(1):164-70. PubMed ID: 8573124 [TBL] [Abstract][Full Text] [Related]
2. Adoptive immunotherapy with murine tumor-specific T lymphocytes engineered to secrete interleukin 2. Nakamura Y; Wakimoto H; Abe J; Kanegae Y; Saito I; Aoyagi M; Hirakawa K; Hamada H Cancer Res; 1994 Nov; 54(22):5757-60. PubMed ID: 7525049 [TBL] [Abstract][Full Text] [Related]
3. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645 [TBL] [Abstract][Full Text] [Related]
4. Induction of potent antitumor response by vaccination with tumor lysate-pulsed macrophages engineered to secrete macrophage colony-stimulating factor and interferon-gamma. Lei H; Ju DW; Yu Y; Tao Q; Chen G; Gu S; Hamada H; Cao X Gene Ther; 2000 Apr; 7(8):707-13. PubMed ID: 10800095 [TBL] [Abstract][Full Text] [Related]
5. Macrophage-derived chemokine gene transfer results in tumor regression in murine lung carcinoma model through efficient induction of antitumor immunity. Guo J; Wang B; Zhang M; Chen T; Yu Y; Regulier E; Homann HE; Qin Z; Ju DW; Cao X Gene Ther; 2002 Jun; 9(12):793-803. PubMed ID: 12040461 [TBL] [Abstract][Full Text] [Related]
6. In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes. Hwu P; Yang JC; Cowherd R; Treisman J; Shafer GE; Eshhar Z; Rosenberg SA Cancer Res; 1995 Aug; 55(15):3369-73. PubMed ID: 7614473 [TBL] [Abstract][Full Text] [Related]
7. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy. Merritt RE; Yamada RE; Crystal RG; Korst RJ J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342 [TBL] [Abstract][Full Text] [Related]
8. Engineered CD8+ cytotoxic T cells with fiber-modified adenovirus-mediated TNF-alpha gene transfection counteract immunosuppressive interleukin-10-secreting lung metastasis and solid tumors. Ye Z; Shi M; Chan T; Sas S; Xu S; Xiang J Cancer Gene Ther; 2007 Jul; 14(7):661-75. PubMed ID: 17479109 [TBL] [Abstract][Full Text] [Related]
9. Intensification of antitumor effect by T helper 1-dominant adoptive immunogene therapy for advanced orthotopic colon cancer. Nakamori M; Iwahashi M; Nakamura M; Ueda K; Zhang X; Yamaue H Clin Cancer Res; 2003 Jun; 9(6):2357-65. PubMed ID: 12796406 [TBL] [Abstract][Full Text] [Related]
10. Successful adoptive immunotherapy of murine poorly immunogenic tumor with specific effector cells generated from gene-modified tumor-primed lymph node cells. Tanaka H; Yoshizawa H; Yamaguchi Y; Ito K; Kagamu H; Suzuki E; Gejyo F; Hamada H; Arakawa M J Immunol; 1999 Mar; 162(6):3574-82. PubMed ID: 10092816 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-18 gene transfer increases antitumor effects of suicide gene therapy through efficient induction of antitumor immunity. Ju DW; Yang Y; Tao Q; Song WG; He L; Chen G; Gu S; Ting CC; Cao X Gene Ther; 2000 Oct; 7(19):1672-9. PubMed ID: 11083476 [TBL] [Abstract][Full Text] [Related]
12. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation. Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491 [TBL] [Abstract][Full Text] [Related]
13. Route of administration influences the antitumor effects of bone marrow-derived dendritic cells engineered to produce interleukin-12 in a metastatic mouse prostate cancer model. Saika T; Satoh T; Kusaka N; Ebara S; Mouraviev VB; Timme TL; Thompson TC Cancer Gene Ther; 2004 May; 11(5):317-24. PubMed ID: 15044961 [TBL] [Abstract][Full Text] [Related]
14. Intratumoral IL-18 gene transfer improves therapeutic efficacy of antibody-targeted superantigen in established murine melanoma. Wang Q; Yu H; Ju DW; He L; Pan JP; Xia DJ; Zhang LH; Cao X Gene Ther; 2001 Apr; 8(7):542-50. PubMed ID: 11319621 [TBL] [Abstract][Full Text] [Related]
15. Enhanced antimetastatic effect of fetal liver kinase 1 extracellular domain and interferon-gamma fusion gene-modified dendritic cell vaccination. Pan J; Heiser A; Marget M; Steinmann J; Kabelitz D Gene Ther; 2005 May; 12(9):742-50. PubMed ID: 15729371 [TBL] [Abstract][Full Text] [Related]
16. Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer. Zhang Q; Yang X; Pins M; Javonovic B; Kuzel T; Kim SJ; Parijs LV; Greenberg NM; Liu V; Guo Y; Lee C Cancer Res; 2005 Mar; 65(5):1761-9. PubMed ID: 15753372 [TBL] [Abstract][Full Text] [Related]
17. Efficient inducation of local and systemic antitumor immune response by liposome-mediated intratumoral co-transfer of interleukin-2 gene and interleukin-6 gene. Cao X; Wang Q; Ju DW; Tao Q; Wang J J Exp Clin Cancer Res; 1999 Jun; 18(2):191-200. PubMed ID: 10464706 [TBL] [Abstract][Full Text] [Related]
18. Efficient generation of autologous peripheral blood-derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80-adenovirus together with interleukin 12 and interleukin 2. Mogi S; Ebata T; Setoguchi Y; Fujime M; Heike Y; Kohsaka T; Yagita H; Okumura K; Azuma M Clin Cancer Res; 1998 Mar; 4(3):713-20. PubMed ID: 9533541 [TBL] [Abstract][Full Text] [Related]
19. Persistent, antigen-specific, therapeutic antitumor immunity by dendritic cells genetically modified with an adenoviral vector to express a model tumor antigen. Song W; Tong Y; Carpenter H; Kong HL; Crystal RG Gene Ther; 2000 Dec; 7(24):2080-6. PubMed ID: 11223988 [TBL] [Abstract][Full Text] [Related]
20. Cytotoxic T lymphocyte therapy of cancer and tumor escape mechanisms. Melief CJ; Kast WM Semin Cancer Biol; 1991 Oct; 2(5):347-54. PubMed ID: 1773050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]